Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.230
+0.030 (2.50%)
Aug 4, 2026, 4:00 PM EDT - Market closed
Biomea Fusion Employees
Biomea Fusion had 40 employees as of March 31, 2026. The number of employees decreased by 1 or -2.44% since the number was last reported on December 31, 2025.
Employees
40
Change
-1
Growth
-2.44%
Revenue / Employee
n/a
Profits / Employee
-$1,123,750
Market Cap
88.93M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 40 | -1 | -2.44% |
| Dec 31, 2025 | 41 | -65 | -61.32% |
| Dec 31, 2024 | 106 | 3 | 2.91% |
| Dec 31, 2023 | 103 | 20 | 24.10% |
| Dec 31, 2022 | 83 | 32 | 62.75% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Fortress Biotech | 78 |
| Verrica Pharmaceuticals | 76 |
| PolyPid | 75 |
| Cognition Therapeutics | 14 |
| Alterity Therapeutics | 9 |
| Rallybio | 9 |
| Aldeyra Therapeutics | 7 |
BMEA News
- 7 weeks ago - Biomea Fusion Transcript: AGM 2026 - Transcripts
- 2 months ago - Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study - GlobeNewsWire
- 2 months ago - Biomea Fusion management to meet with Citizens - TheFly
- 2 months ago - Biomea Fusion Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Biomea Fusion partners with University of Leicester on obesity study - TheFly
- 2 months ago - Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity - GlobeNewsWire
- 2 months ago - Biomea Fusion Slides: Corporate presentation - Filings
- 2 months ago - Biomea Fusion Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts